- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Menu
Menu
Menu
Menu
Menu
Brand Name :
Synonyms :
Class :
It may diminish the effect when combined with phenobarbital by affecting the intestinal/hepatic enzyme CYP3A4 metabolism
atazanavir: they may diminish the serum concentration of hormonal contraceptives
atazanavir: they may diminish the serum concentration of hormonal contraceptives
atazanavir: they may diminish the serum concentration of hormonal contraceptives
atazanavir: they may diminish the serum concentration of hormonal contraceptives
atazanavir: they may diminish the absorption of antacids
atazanavir: they may diminish the absorption of antacids
atazanavir: they may diminish the absorption of antacids
atazanavir: they may diminish the absorption of antacids
atazanavir: they may diminish the absorption of antacids
when both drugs are combined, there may be an increased risk of adverse effects
may increase the level of each other by unknown mechanism
may diminish the serum concentration of PHENobarbital
drospirenone/ethinyl estradiol/levomefolate
may diminish the serum concentration of Hormonal Contraceptives
may diminish the absorption of each other when combined
may diminish the absorption of magnesium salts
etonogestrel/ethinyl estradiol
may diminish the serum concentration of Hormonal Contraceptives
It may enhance toxicity when combined with cholic acid by diminishing the elimination
it decreases the rate of elimination of pidotimod
when both drugs are combined, the metabolism of paclitaxel increases
when both drugs are combined, there may be an increased effect of cabozantinib by affecting hepatic or intestinal enzyme cyp3a4 metabolism
when both drugs are combined, there may be a reduced level of the serum concentration of atazanavir
when both drugs are combined, there may be an increased risk or severity of adverse effects
when both drugs are combined, there may be an increased level or effect of romidepsin by affecting hepatic or intestinal enzyme cyp3a4 metabolism
CYP3A strong enhancers of the small intestine may reduce the bioavailability of atazanavir
atazanavir increases the effect or level of midostaurin by altering the CYP3A4 enzyme metabolism
atazanavir increases the effect or level of midostaurin by altering the CYP3A4 enzyme metabolism
it increases the effect or level of ruxolitinib by altering the intestinal or hepatic CYP3A4 enzyme metabolism
may diminish the serum concentration of buprenorphine
may enhance the serum concentration of elbasvir/grazoprevir
rifampin: they may diminish the serum concentration of atazanavir
may diminish the serum concentration of buprenorphine
it may decrease the serum concentration of Atazanavir
it may decrease the serum concentration of Atazanavir
it may decrease the serum concentration of Atazanavir
it may decrease the serum concentration of Atazanavir
it may decrease the serum concentration of Atazanavir
may increase the serum concentration when both drugs are combined
atazanavir: they may enhance serum concentrations of the of rifabutin
methadone concentration serum may be reduced by atazanavir
may diminish the concentration of serum when combined with atazanavir
may diminish the concentration of serum when combined with atazanavir
may diminish the concentration of serum when combined with atazanavir
may diminish the concentration of serum when combined with atazanavir
may diminish the concentration of serum when combined with atazanavir
It may enhance the levels when combined with tamsulosin by affecting CYP3A4 metabolism
it may enhance the metabolism when combined with oxcarbazepine
atazanavir has the potential to reduce the rate of excretion of idebenone, leading to an elevation in levels of serum
Combining tegafur with atazanavir can reduce tegafur’s metabolism
When loracarbef is used together with atazanavir, the risk or seriousness of nephrotoxicity is enhanced
when both drugs combine atazanavir will increase effect of ifosfamide by affecting the enzyme CYP3A4 metabolism.
cyclophosphamide effect of action increased by affecting enzyme CYP3A4 metabolism.
atazanavir on interacting with brentuximab has its effect increased by altering the intestinal or hepatic CYP3A4 enzyme metabolism.
when both drugs are combined, there may be a reduced metabolism of erlotinib
increases serum level of cabazitaxel by affecting the enzyme CYP3A4
May enhances the effects of the other by pharmacodynamic synergism
may increase the level by affecting hepatic enzyme CYP3A4 metabolism
may increase the level by affecting the hepatic enzyme CYP3A4 metabolism
it increases by affecting the hepatic enzyme CYP3A4 metabolism
relugolix/estradiol/norethindrone
it decreases by affecting the hepatic enzyme CYP3A4 metabolism
may increase the serum concentration when it is combined
atazanavir, when taken with ixazomib, alters the intestinal/hepatic CYP3A4 enzyme metabolism
it decreases the concentration of hormonal contraceptives in serum
may increase the level by affecting the hepatic enzyme CYP3A4 metabolism
ADVERTISEMENT
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
USA – BOSTON
60 Roberts Drive, Suite 313
North Adams, MA 01247
INDIA – PUNE
7, Shree Krishna, 2nd Floor, Opp Kiosk Koffee, Shirole Lane, Off FC Road, Pune 411004, Maharashtra
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
MASSACHUSETTS – USA
60 Roberts Drive, Suite 313,
North Adams, MA 01247
MAHARASHTRA – INDIA
7, Shree Krishna, 2nd Floor,
Opp Kiosk Koffee,
Shirole Lane, Off FC Road,
Pune 411004, Maharashtra
